The effect of the GLP-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes:a randomized double-blind placebo-controlled cross over study
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker

Odense University Hospital, Odense (Denmark)
47 More presentations in this session
Associate Professor A. Kovacs (Budapest, HU)
Doctor A. Ayesta Lopez (Madrid, ES)
Associate Professor E. Bollano (Gothenburg, SE)
Doctor S. Stampfli (Lucerne, CH)
Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016
